Michael Manning Collier, Executive Vice President of HealthStream Inc (NASDAQ:HSTM), filed a Form 4 on September 22, 2026, reporting the acquisition of three separate restricted share unit grants on September 18, 2026, and disclosing a direct beneficial ownership of 60,293 shares of common stock.

Key Highlights

  • Three RSU grants awarded: Collier acquired 2,566, 15,395, and 5,132 restricted share units on September 18, 2026, totaling 23,093 RSUs.
  • Price of derivative securities: All three RSU grants were acquired at $0 per unit, according to the filing.
  • Post-transaction ownership: Collier beneficially owned 60,293 shares of common stock directly following the reported transactions.
  • Time-based vesting (2,566 RSUs): These vest over four years: 15% on September 18, 2027; 20% on September 18, 2028; 30% on September 18, 2029; and 35% on September 18, 2030.
  • Equal-installment vesting (15,395 RSUs): These vest annually in four equal installments beginning September 18, 2027, contingent on continued service.
  • Performance-based vesting (5,132 RSUs): Up to 25% may vest annually beginning February 23, 2028 through February 23, 2031, subject to performance criteria set by the Compensation Committee each year.

HealthStream EVP Collier's September 2026 RSU Award Details

According to the filing, Michael Manning Collier, who serves as Executive Vice President of HealthStream Inc, received three separate restricted share unit grants on September 18, 2026, each representing the contingent right to receive one share of common stock upon vesting. All three grants are held directly and were acquired at a stated price of $0.

The first grant of 2,566 RSUs follows a graduated four-year vesting schedule tied to continued service: 15% vest on September 18, 2027; 20% on September 18, 2028; 30% on September 18, 2029; and the remaining 35% on September 18, 2030. The second grant of 15,395 RSUs also requires continued service but vests in four equal annual installments beginning September 18, 2027, the filing states.

The third grant of 5,132 RSUs introduces a performance condition. According to the filing, vesting is "contingent upon continued service at the time of vesting and the achievement of certain performance criteria," with the Compensation Committee of the Board of Directors establishing those criteria on an annual basis. Up to 25% of these units may vest each year beginning February 23, 2028 and through February 23, 2031, based on annual performance periods. The filing further notes that "RSUs that do not vest during a performance period may become eligible for vesting during the next performance period."

What Was Disclosed

The filing reported three RSU grants totaling 23,093 units awarded to HealthStream's Executive Vice President on September 18, 2026, with vesting terms ranging from time-based schedules to performance-contingent criteria, and post-transaction direct beneficial ownership of 60,293 common shares.